DSpace at RU >

Browsing by Author Vignetti, M.

Full Text	Issue Date	Title	Author(s)
	2010	Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19).	Amadori, S.; Suciu, S.; Selleslag, D.; Stasi, R.; Alimena, G., et al
	2009	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.	Mandelli, F.; Vignetti, M.; Suciu, S.; Stasi, R.; Petti, M.C., et al
	2007	Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.	Thomas, X.; Suciu, S.; Rio, B.; Leone, G.; Broccia, G., et al
	2005	Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia Groups.	Amadori, S.; Suciu, S.; Stasi, R.; Willemze, R.; Mandelli, F., et al
	2005	Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study.	Amadori, S.; Suciu, S.; Jehn, U.; Stasi, R.; Thomas, X., et al
	2004	Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.	Amadori, S.; Suciu, S.; Willemze, R.; Mandelli, F.; Selleslag, D., et al